Gordion Bioscience

Operater of a biotechnology company intended to find patterns in real tumor data that can transform drug development. The company offers pathway analysis powered by dark genome data which are mapped in thousands of tumor genomes providing a deep understanding of tumor biology and revealing novel therapeutic opportunities, enabling patients to get better drugs.